2cureX AB (2CUREX) - Cash Flow Conversion Efficiency

Latest as of June 2025: 3.288x

Based on the latest financial reports, 2cureX AB (2CUREX) has a cash flow conversion efficiency ratio of 3.288x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr2.06 Million ≈ $221.47K USD) by net assets (Skr626.00K ≈ $67.37K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 2cureX AB market cap and net worth for the company's overall valuation and market capitalisation.

2cureX AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how 2cureX AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

2cureX AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of 2cureX AB ranked by their cash flow conversion efficiency. See 2CUREX cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
BEACN Wizardry & Magic Inc V:BECN	0.886x
Starbox Group Holdings Ltd. Ordinary Shares NASDAQ:STBX	-0.001x
Goldhills Holding Ltd V:GHL	0.014x
Internet Gold Golden Lines Ltd TA:IGLD	1.079x
Chariot Oil & Gas Limited LSE:CHAR	-0.033x
Universal Ibogaine Inc V:IBO	-0.405x
Handal Resources Bhd KLSE:7253	-0.229x
The Pebble Group PLC LSE:PEBB	0.180x

Annual Cash Flow Conversion Efficiency for 2cureX AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of 2cureX AB from 2015 to 2024. View 2CUREX share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr5.10 Million ≈ $548.73K	Skr-4.63 Million ≈ $-497.83K	-0.907x	+64.90%
2023-12-31	Skr12.08 Million ≈ $1.30 Million	Skr-31.22 Million ≈ $-3.36 Million	-2.585x	-297.53%
2022-12-31	Skr43.03 Million ≈ $4.63 Million	Skr-27.98 Million ≈ $-3.01 Million	-0.650x	-162.37%
2021-12-31	Skr74.34 Million ≈ $8.00 Million	Skr-18.43 Million ≈ $-1.98 Million	-0.248x	-24.76%
2020-12-31	Skr58.86 Million ≈ $6.33 Million	Skr-11.69 Million ≈ $-1.26 Million	-0.199x	+29.07%
2019-12-31	Skr28.08 Million ≈ $3.02 Million	Skr-7.86 Million ≈ $-846.29K	-0.280x	-431.76%
2018-12-31	Skr13.62 Million ≈ $1.47 Million	Skr1.15 Million ≈ $123.76K	0.084x	+139.30%
2017-12-31	Skr20.24 Million ≈ $2.18 Million	Skr-4.35 Million ≈ $-467.91K	-0.215x	-240.95%
2016-12-31	Skr7.91 Million ≈ $851.78K	Skr1.21 Million ≈ $129.84K	0.152x	+160.87%
2015-12-31	Skr8.19 Million ≈ $881.25K	Skr-2.05 Million ≈ $-220.70K	-0.250x	--

About 2cureX AB

ST:2CUREX Sweden Biotechnology

Market Cap

$1.13 Million

Skr10.54 Million SEK

Market Cap Rank

#30617 Global

#708 in Sweden

Share Price

Skr0.42

Change (1 day)

-12.13%

52-Week Range

Skr0.42 - Skr2.65

All Time High

Skr28.20